| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gaurav Aggarwal | Director | $8,430,499 | 25 Aug 2025 | ||
| Pramod Gupta | EVP, Pharmaceuticals and BD | 28 Jul 2025 | |||
| Shalabh K. Gupta | CEO, Director | 28 Jul 2025 | |||
| John L. Ryan | Director | 05 Sep 2023 | |||
| Sara Kenkare-Mitra | Director | 28 Jul 2025 | |||
| John Townsend | Chief Financial Officer | 28 Jul 2025 | |||
| Douglas Jermasek | EVP of Corporate Strategy | 28 Jul 2025 | |||
| Brigitte Schiller | Director | 15 Jul 2022 | |||
| Sandeep Laumas | Director | 28 Jul 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gaurav Aggarwal | UNCY | Common Stock | Conversion of derivative security | 57.4% | 652,900 | 1,789,915 | 25 Aug 2025 | By Vivo Opportunity Fund Holdings L.P. | ||
| Gaurav Aggarwal | UNCY | Series A-2 Prime Preferred Stock | Disposed to Issuer | -100% | -3,199 | 0 | 25 Aug 2025 | By Vivo Opportunity Fund Holdings L.P. | ||
| Gaurav Aggarwal | UNCY | Stock Options | Award | 117.8% | 21,200 | 39,200 | 28 Jul 2025 | Direct | ||
| Sandeep Laumas | UNCY | Stock Options | Award | 105.6% | 21,200 | 41,286 | 28 Jul 2025 | Direct | ||
| Sara Kenkare-Mitra | UNCY | Stock Options | Award | 117.8% | 21,200 | 39,200 | 28 Jul 2025 | Direct | ||
| Shalabh K. Gupta | UNCY | Stock Options | Award | 50.5% | 325,000 | 968,951 | 28 Jul 2025 | Direct | ||
| John Townsend | UNCY | Stock Options | Award | 10.9% | 10,000 | 101,557 | 28 Jul 2025 | Direct | ||
| Pramod Gupta | UNCY | Stock Options | Award | 42.5% | 90,000 | 301,986 | 28 Jul 2025 | Direct | ||
| Douglas Jermasek | UNCY | Stock Options | Award | 4.87% | 10,000 | 215,500 | 28 Jul 2025 | Direct |